Andres F. Zuluaga

Medellin, ANT, CO 
Medellin, ANT, CO 

Overview

Andres Zuluaga practices practicing medicine in Medellin, Colombia.

His clinical expertise encompasses Pernicious Anemia, Eosinophilic Asthma, Palatal Myoclonus, and Endocarditis.

He is actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Medellin, ANT, Colombia
Other Locations
Antioquia, ANT, Colombia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Inactivated Convalescent Plasma as a Therapeutic Alternative in Hospitalized Patients CoViD-19
Inactivated Convalescent Plasma as a Therapeutic Alternative in Hospitalized Patients CoViD-19
Enrollment Status: Unknown
Publish Date: June 02, 2020
Intervention Type: Drug
Study Drugs: Inactivated Convalescent Plasma, Support Treatment
Study Phase: Phase 2

45 Total Publications

Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti-Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists.
Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti-Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists.
Journal: Pharmacotherapy
Published: October 03, 2025

Frequently Asked Questions about Andres F. Zuluaga

Is Andres F. Zuluaga a top-rated expert for Pernicious Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Andres F. Zuluaga is classified as an Experienced expert for Pernicious Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andres F. Zuluaga participate in research or clinical trials?

Yes. Andres F. Zuluaga has published 45 articles and abstracts on conditions like Pernicious Anemia. You can view a list of Andres F. Zuluaga's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zuluaga's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile